These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 17913382)
1. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension. Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382 [TBL] [Abstract][Full Text] [Related]
2. Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction. Qipshidze N; Tyagi N; Metreveli N; Lominadze D; Tyagi SC Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H688-96. PubMed ID: 22101525 [TBL] [Abstract][Full Text] [Related]
3. Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels. Hessel M; Steendijk P; den Adel B; Schutte C; van der Laarse A Cell Physiol Biochem; 2009; 24(3-4):201-10. PubMed ID: 19710535 [TBL] [Abstract][Full Text] [Related]
4. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload. Apitz C; Honjo O; Humpl T; Li J; Assad RS; Cho MY; Hong J; Friedberg MK; Redington AN J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1494-501. PubMed ID: 22818124 [TBL] [Abstract][Full Text] [Related]
5. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat. Kögler H; Hartmann O; Leineweber K; Nguyen van P; Schott P; Brodde OE; Hasenfuss G Circ Res; 2003 Aug; 93(3):230-7. PubMed ID: 12842921 [TBL] [Abstract][Full Text] [Related]
6. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263 [TBL] [Abstract][Full Text] [Related]
7. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668 [TBL] [Abstract][Full Text] [Related]
8. Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide. Chen L; Gan XT; Haist JV; Feng Q; Lu X; Chakrabarti S; Karmazyn M J Pharmacol Exp Ther; 2001 Aug; 298(2):469-76. PubMed ID: 11454907 [TBL] [Abstract][Full Text] [Related]
9. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775 [TBL] [Abstract][Full Text] [Related]
10. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension. Broderick TL; King TM Med Sci Monit; 2008 Dec; 14(12):BR261-4. PubMed ID: 19043358 [TBL] [Abstract][Full Text] [Related]
12. Ca Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917 [TBL] [Abstract][Full Text] [Related]
13. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat. Lamberts RR; Vaessen RJ; Westerhof N; Stienen GJ Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361 [TBL] [Abstract][Full Text] [Related]
14. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling. Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365 [TBL] [Abstract][Full Text] [Related]
15. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. Gao S; Long CL; Wang RH; Wang H Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734 [TBL] [Abstract][Full Text] [Related]